<\/b><\/p>\n
<\/b><\/p>\n
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.<\/p>\n
COVID-19 Tests for Return to Work May Delay Health Workers<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Health care workers (HCWs) diagnosed with COVID-19 can have a prolonged recovery of viral RNA, which can delay return to work (RTW), according to research published online Aug. 26 in Infection Control & Hospital Epidemiology<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n COVID-19-Related Hospital Death Up With Psychiatric Diagnosis<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Patients with any prior psychiatric diagnosis have an increased risk for COVID-19-related hospital death, according to a research letter published online Sept. 30 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Recent Increase Seen in COVID-19 Incidence Among 18- to 22-Year-Olds<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — During Aug. 2 to Sept. 5, 2020, there was a 55.1 percent increase in the weekly incidence of COVID-19 nationally among young adults aged 18 to 22 years, according to research published in the Sept. 29 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n No Race Difference Found in COVID-19 Mortality Rates at Same Medical Center<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — For admitted COVID-19 patients presenting to the same urban medical center, risk-adjusted outcomes were no worse for non-Hispanic Black and Hispanic patients versus non-Hispanic White patients, according to a study published online Sept. 25 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Current Trends in COVID-19 Reported for U.S. Youth<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — The incidence of COVID-19 was higher in adolescents than among children during May to September 2020, according to research published in the Sept. 28 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Hospital Admissions Not Related to COVID-19 Fell in Early 2020<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n CDC Recommends No Travel for Thanksgiving<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — Families who usually travel to see each other on Thanksgiving should stay home and hold virtual celebrations instead, the U.S. Centers for Disease Control and Prevention says in guidance on holiday safety during the COVID-19 pandemic.<\/p>\n CBS News<\/i> Article<\/a><\/p>\n Global Death Toll From COVID-19 Passes 1 Million<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — The global COVID-19 pandemic reached a grim new milestone on Tuesday: 1 million dead.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Johns Hopkins University<\/a><\/p>\n U.S. Government to Ship Millions of Rapid COVID-19 Tests This Week<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — The U.S. government will start distributing millions of rapid COVID-19 tests to states this week with the goal of reopening schools.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Thousands of Donated Corneas From Gay, Bisexual Men Rejected<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — An estimated 1,558 to 3,217 corneal donations were disqualified in 2018 because of federal regulations prohibiting corneal donation by men who have sex with men (MSM), according to a study published online Sept. 24 in JAMA Ophthalmology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n Outcomes of In-Hospital Cardiac Arrest Poor in COVID-19 Patients<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — None of 54 patients hospitalized with COVID-19 with in-hospital cardiac arrest who underwent cardiopulmonary resuscitation (CPR) survived to discharge, according to a research letter published online Sept. 28 in JAMA Internal Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n Brain-Eating Amoeba Found in Tap Water of Lake Jackson, Texas<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — The presence of a brain-eating amoeba in its drinking water has led the city of Lake Jackson, Texas, to issue a “do not use water order” and request an emergency declaration from the state.<\/p>\n CBS News<\/i> Article<\/a><\/p>\n Private Health Plans Pay Hospitals 247 Percent of Medicare<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.<\/p>\n More Information<\/a><\/p>\n Infants of COVID-19-Infected Mothers Doing Well in Short Term<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Infants born to mothers testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not have a higher frequency of adverse outcomes than those born to mothers testing negative, according to a brief report published online Sept. 18 in Clinical Infectious Diseases<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Hydroxychloroquine Tied to Heart Problems Prior to Pandemic<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Real-world, pre-COVID-19 adverse events data show hydroxychloroquine (HCQ) and chloroquine (CQ) are associated with cardiovascular adverse events (CVAEs), according to a study published online Sept. 22 in the British Journal of Clinical Pharmacology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Clinical Severity Lower With Vitamin D Sufficiency in COVID-19<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Vitamin D sufficiency is associated with reduced clinical severity, inpatient mortality, and serum levels of C-reactive protein (CRP) among patients infected with COVID-19, according to a study published online Sept. 25 in PLOS ONE<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Only Two-Thirds of Parents Planning to Get Flu Shots for Their Children<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — One-third of parents say they will forgo the flu vaccination for their children this year, despite public health recommendations, according to the C.S. Mott Children’s Hospital National Poll on Children’s Health.<\/p>\n More Information<\/a><\/p>\n <10 Percent of U.S. Population Has Antibodies to SARS-CoV-2<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Fewer than 10 percent of the U.S. adult population formed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the pandemic, according to a study published online Sept. 25 in The Lancet<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Wood Ear Mushrooms Linked to Salmonella<\/i> Outbreak<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — Recalled wood ear mushrooms imported by Wismettac Asian Foods Inc., of Santa Fe Springs, California, and sold to restaurants may be linked to a multistate Salmonella<\/i> outbreak, the U.S. Food and Drug Administration said Thursday.<\/p>\n More Information<\/a><\/p>\n Physician’s Briefing Weekly Coronavirus Roundup<\/font><\/p>\n Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 21 to 25, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n U.S. Non-English Speakers Less Likely to Have SARS-CoV-2 Test<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — Non-English speakers are less likely to have completed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and have a higher proportion of positive tests compared with English speakers, according to a research letter published online Sept. 24 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n One-Fifth of Those With SARS-CoV-2 Infection Asymptomatic<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — About one-fifth of individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are asymptomatic and their viral load is comparable to that of patients with mild symptoms, according to a study published online Sept. 22 in Thorax<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Median Age of COVID-19 Cases Declined in May to August in U.S.<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — From May to August 2020, there was a decrease in the median age of COVID-19 cases in the United States, according to research published in the Sept. 23 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n ACIP Provides Recommendations on Meningococcal Vaccination<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — Routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended for adolescents aged 11 to 12 years with a booster at age 16 years, according to a report published in the Sept. 24 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Performance of Commercial SARS-CoV-2 Ab Tests Varies<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — There is considerable variation in the performance of commercial kits for detecting antibodies against SARS-CoV-2, according to a study published online Sept. 24 in PLOS Pathogens<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Children’s Routine Care Plummets During Pandemic<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — There has been a steep drop in routine medical care for low-income children in the United States during the pandemic, which could cause long-term problems, the U.S. Centers for Medicare & Medicaid Services says.<\/p>\n AP News<\/i> Article<\/a><\/p>\n United First U.S. Airline to Offer COVID-19 Testing for Passengers<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — The first COVID-19 testing program for airline passengers in the United States will be introduced Oct. 15 by United Airlines.<\/p>\n CBS News<\/i> Article<\/a><\/p>\n Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — A Chinese pharmaceutical company claims its COVID-19 vaccine should available by early next year for distribution in the United States and other countries.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Public Awareness Low for Invasive Fungal Diseases<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — More than two-thirds of individuals have never heard of any of six invasive fungal diseases, according to research published in the Sept. 25 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Acute Kidney Injury Ups Risk for Death in COVID-19 Patients<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — Acute kidney injury (AKI) in hospitalized patients with COVID-19 is associated with a significantly higher risk for in-hospital death, according to a study published online Sept. 19 in the American Journal of Kidney Diseases<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n COVID-19 Risk in Assisted Living Similar to Nursing Homes<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — Individual-level risk factors associated with an increased risk for COVID-19 in assisted living (AL) facilities are the same as those seen in nursing homes, according to a study published online Sept. 21 in the Journal of the American Geriatrics Society<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n As Flu Season Approaches, Clinicians Brace for Potential ‘Twindemic’<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Flu shots may be more important than ever this year, as COVID-19 presents new challenges for clinicians and communities this flu season. HD Live! spoke with Nadia Eltaki, M.D., director of clinical operations at Sibley Memorial Hospital in Washington, D.C., to discuss how clinicians can potentially lessen the potential for an overlapping superinfection, or “twindemic.”<\/p>\n More Information<\/a><\/p>\n U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The U.S. COVID-19 death toll reached the tragic milestone of 200,000 on Tuesday, with at least 22 states now reporting a rise in new cases. Just last Monday, only nine states were reporting increases in new COVID-19 cases, CNN<\/i> reported. For the most part, the case spikes are showing up in the country’s heartland and the Midwest.<\/p>\n CNN<\/i> Article<\/a><\/p>\n J&J COVID-19 Vaccine Begins Final Stage of Clinical Trials<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The final stage of clinical trials for Johnson & Johnson’s COVID-19 vaccine have started, the company announced Tuesday.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n Stricter Vaccine Approval Rules Coming From FDA<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Stricter guidelines for emergency use authorization of a vaccine against the new coronavirus could soon be issued by the U.S. Food and Drug Administration.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n SARS-CoV-2 Mortality Mainly Linked to Older Age, Comorbidity<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For U.S. veterans with COVID-19, mortality is mainly associated with older age, male sex, and comorbidity, according to a study published online Sept. 23 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Red Blood Cell Distribution Width, Mortality Tied in COVID-19<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For patients with COVID-19, elevated red blood cell distribution width (RDW) is associated with increased mortality risk, according to a study published online Sept. 23 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Negative Pressure Does Not Cut C-Section Infection Risk in Obese<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Compared with standard wound care, prophylactic negative pressure wound therapy does not lower the risk for surgical-site infection in obese women following cesarean delivery, according to a study published in the Sept. 22\/29 issue of the Journal of the American Medical Association<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Most People With SARS-CoV-2 Do Not Remain Asymptomatic<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Most people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not remain asymptomatic, and the secondary attack rate is lower among contacts of people with asymptomatic infection, according to a review published online Sept. 22 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n AKI Occurs in 7 Percent of Those Hospitalized With COVID-19<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Acute kidney injury (AKI) occurs in 7 percent of patients hospitalized with COVID-19 and is associated with increased in-hospital mortality, according to a study published online Sept. 22 in the Clinical Journal of the American Society of Nephrology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Rates of COVID-19 Infection Higher in Blacks, Hispanics<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Black and Hispanic individuals are experiencing an excess burden of severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Sept. 22 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n PrEP Prescribing Low in the U.S., Even Among HIV Care Providers<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Even among HIV-focused practitioners, preexposure prophylaxis (PrEP) prescribing is not routine, according to a study published online Sept. 3 in PLOS ONE<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Glucocorticoids Linked to Hospitalized Infection Risk in RA<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — For patients with rheumatoid arthritis (RA) receiving disease-modifying antirheumatic drug (DMARD) therapy, continued use of glucocorticoids is associated with an increased risk for hospitalized infections, according to a study published online Sept. 22 in the Annals of Internal Medicine<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n Many School Employees at Increased Risk for Severe COVID-19<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — Nearly half of all school employees meet the U.S. Centers for Disease Control and Prevention definition for increased or potentially increased risk for severe COVID-19, according to a study published online Sept. 17 in Health Affairs<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n CDC Removes New COVID-19 Guidelines Just Days After Posting Them<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — New U.S. Centers for Disease Control and Prevention website guidelines suggesting that the new coronavirus can be transmitted by tiny droplets over a distance greater than six feet and that indoor ventilation is crucial to prevent its spread were removed from the agency’s website late Monday morning.<\/p>\n The Washington Post<\/i> Article<\/a><\/p>\n AstraZeneca Releases COVID-19 Vaccine Trial Plans<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — AstraZeneca is the latest drug company to release details about human tests of its COVID-19 vaccine in response to public demand for such information. Americans have increasing doubts about a COVID-19 vaccine, and experts are worried that an unproven or unsafe vaccine may be released prematurely due to pressure from President Donald Trump, The New York Times<\/i> reported.<\/p>\n